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Transient elastography (TE; Fibroscan) is a noninvasive
diagnostic tool designed by Echosens (Paris, France) to
evaluate liver fibrosis. Its working principle is to place the
probe on the liver surface, followed by generation of low
frequency, low amplitude (50 Hz) vibrations transmitted by
the vibrator in the probe, which introduces minor liver
deformation, thus triggering an elastic shear wave that
propagates through the liver tissue. In addition, pulse-echo
ultrasound waves obtained by the transducer probe are
used to analyze the velocity of the elastic shear wave
within tissues, which can be used to measure liver stiffness
using the equation E(kPa) Z 3rV2, where E is elastic
modulus, r is mass density, and V is shear velocity (Fig. 1).
In general, TE using the standard M probe measures a cy-
lindrical volume approximately 1 cm in diameter and 4 cm
in length, 25e65 mm underneath the skin surface. More-
over, the E is considered reliable when the following
criteria are met: the success rate (number of valid acqui-
sitions divided by the number of attempts) is over 60% and
the ratio of the interquartile range to the median of 10
measurements should not be 30% greater than median.
Assessment of liver fibrosis severity
Invasive liver biopsy has traditionally been used to evaluate
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complications and the accuracy of tissue sampling by nee-
dle biopsy tends to be impacted by the quality of the tissue
samples obtained. A large number of studies have described
the application of TE in diagnosing different types of liver
disease.Chronic hepatitis C
By now, the efficacy of TE in chronic hepatitis C has been
most extensively established. To assess the severity of liver
fibrosis (F0eF4; 0: no fibrosis, 1: mild fibrosis, 2: moderate
fibrosis, 3: severe fibrosis, 4: liver cirrhosis), liver fibrosis
stages have been defined as F2 (if E > 7.1 kPa),  F3 (if
E > 9.5 kPa), and F4 (if E > 12.5 to 14.6 kPa).Chronic hepatitis B
The severity of liver fibrosis has been defined as follows:
F2 if E > 7.0 kPa; F3 if E > 8.4 kPa; and F4 if
E > 13.4 kPa.Other liver diseases
Few studies have chronicled the use of TE in other chronic
liver diseases, including alcoholic and nonalcoholic fatty
liver disease, autoimmune liver disease, liver failure after
transplantation, and special populations (e.g., combined
infections of HIV and chronic hepatitis C, dialysis patients
with chronic hepatitis C, and acute hepatitis). The definite
cut-off value of the E for these conditions requires further
confirmation by research.of Ultrasound in Medicine.Open access under CC BY-NC-ND license.
Fig. 1 The principle of transient elastography.
180 C.-H. LiuEvaluation of hepatic venous pressure and
gastroesophageal varices
TE has been proven to be positively correlated with the
hepatic venous pressure gradient. Furthermore, when
E > 13.9e21.3 kPa, the patient is very likely to have been
esophageal varices. If E > 19.0e30.5 kPa, the patient is
likely to have large gastroesophageal varices, which are
prone to bleed easily.
Evaluation of liver cancer
To evaluate chronic hepatitis C-associated liver cancer,
research has indicated that compared to patients with
E < 10.0 kPa, the risk of liver cancer is 17-, 21-, 26-, and 46-
fold greater in patients with E 10.1e15.0 kPa, 15.1e20 kPa,
20.1e25.0 kPa, and > 25.0 kPa, respectively.
Limitations and prospects of TE
Although TE is a convenient, noninvasive diagnostic tool,
many limitations are still associated with this technique.
For obese patients (body mass index > 30 kg/m2),children, or patients with a narrow intercostal space, the
standard M probe may not be able to measure the E or the
fluctuations in measures due to the instability of the
elastic shear wave propagating through the tissue. Oper-
ators can now use probes in sizes XL (for a scanned area
35e75 mm underneath the skin surface) and S (for a
scanned area 15e50 mm underneath the skin surface). In
addition, the instability of energy transmission led by the
propagation of the elastic shear wave through the water
layer and the increased hardness of the liver can result in
high E. In patients with ascites, acute hepatitis, and
obstructive liver disease who have hepatic inflammatory
edema, the severity of liver fibrosis can be overestimated.
For patients with stable liver disease who receive routine
drug treatment, early research has shown the E decreased
in long-term sequential testing. Nonetheless, the value of
TE to diagnose fibrosis evolution via sequential liver bi-
opsies has not been confirmed. In summary, TE is a simple-
to-operate, stable, and noninvasive examination tool that
can be used to detect the severity of liver fibrosis, eval-
uate liver cirrhosis-related complications and assess the
incidence of liver cancer. At present, TE can increase
diagnostic accuracy if probes appropriate to the patient’s
body sizes are used. More attempts to compensate for the
adequacies of this modality will be needed.
